Pharmaceuticals in Russia

MarketLine
38 Pages - MLINE12998
$350.00

Summary

Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Russian pharmaceuticals market had total revenues of $24.5m in 2018, representing a compound annual growth rate (CAGR) of 13.8% between 2014 and 2018.
- The performance of the market is forecast to decelerate, with an anticipated CAGR of 12.8% for the five-year period 2018-2023, which is expected to drive the market to a value of $44.9m by the end of 2023.
- Stagnation in the Russian economy has hindered any growth in pharmaceutical sales, and the industry has shifted to cutting prices to compete.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Russia pharmaceuticals market by value in 2018?
- What will be the size of the Russia pharmaceuticals market in 2023?
- What factors are affecting the strength of competition in the Russia pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Russia’s pharmaceuticals market in relation to its regional counterparts?

'

Table of Contents
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Novartis AG
Sanofi SA
Les Laboratoires Servier
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

List of Tables
Table 1: Russia pharmaceuticals market value: $ billion, 2014-18
Table 2: Russia pharmaceuticals market geography segmentation: $ billion, 2018
Table 3: Russia pharmaceuticals market share: % share, by value, 2018
Table 4: Russia pharmaceuticals market value forecast: $ billion, 2018-23
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Novartis AG: key facts
Table 10: Novartis AG: key financials ($)
Table 11: Novartis AG: key financial ratios
Table 12: Sanofi SA: key facts
Table 13: Sanofi SA: key financials ($)
Table 14: Sanofi SA: key financials (€)
Table 15: Sanofi SA: key financial ratios
Table 16: Les Laboratoires Servier: key facts
Table 17: Russia size of population (million), 2014-18
Table 18: Russia gdp (constant 2005 prices, $ billion), 2014-18
Table 19: Russia gdp (current prices, $ billion), 2014-18
Table 20: Russia inflation, 2014-18
Table 21: Russia consumer price index (absolute), 2014-18
Table 22: Russia exchange rate, 2014-18

List of Figures
Figure 1: Russia pharmaceuticals market value: $ billion, 2014-18
Figure 2: Russia pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 3: Russia pharmaceuticals market share: % share, by value, 2018
Figure 4: Russia pharmaceuticals market value forecast: $ billion, 2018-23
Figure 5: Forces driving competition in the pharmaceuticals market in Russia, 2018
Figure 6: Drivers of buyer power in the pharmaceuticals market in Russia, 2018
Figure 7: Drivers of supplier power in the pharmaceuticals market in Russia, 2018
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2018
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2018
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2018
Figure 11: Bayer AG: revenues & profitability
Figure 12: Bayer AG: assets & liabilities
Figure 13: Novartis AG: revenues & profitability
Figure 14: Novartis AG: assets & liabilities
Figure 15: Sanofi SA: revenues & profitability
Figure 16: Sanofi SA: assets & liabilities

$350.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838